Oxybutynin Chloride NDC 0832-0038

NDC codes

FDA NDC Directory

Product NDC (as listed)0832-0038Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00832-0038Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
0832-0038-00	00832003800	100 TABLET in 1 BOTTLE (0832-0038-00)Marketed from Nov 7, 2011
0832-0038-10	00832003810	1000 TABLET in 1 BOTTLE (0832-0038-10)Marketed from Nov 7, 2011
0832-0038-50	00832003850	500 TABLET in 1 BOTTLE (0832-0038-50)Marketed from Nov 7, 2011

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Oxybutynin Chloride
Generic name (nonproprietary): oxybutynin chloride
Active ingredients: Oxybutynin chloride — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Upsher-Smith Laboratories, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 074625
Marketing start: Nov 7, 2011
Marketing end: Dec 31, 2028
Other FDA classes: Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 0832-0038_45af3420-b44f-39a1-e063-6394a90ad626SPL ID 45af3420-b44f-39a1-e063-6394a90ad626SPL set ID 3ee6835a-7a7d-49a9-8460-2f1dd270ead3RxCUI 863664UNII L9F3D9RENQ
Pharmacologic class: Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400832003800 followed by a unit qualifier and the quantity

Package 00832-0038-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 11, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Oxybutynin chloride tablets, USP are indicated for the relief of symptoms of bladder instability associated with voiding in patients with uninhibited neurogenic or reflex neurogenic bladder (i.e., urgency, frequency, urinary leakage, urge incontinence, dysuria).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 074625

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 074625
Product	Strength	Form · route	Labeler	Product NDC
Oxybutynin Chloride	Oxybutynin chloride 5 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	43353-978